QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 9 January 2007
doi: 10.1242/jcs.03331

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.03331v1 120/3/407    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mebarek, S. Articles by Némoz, G. Search for Related Content PubMed PubMed Citation Articles by Mebarek, S. Articles by Némoz, G.

Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation

¹ INSERM, Unit 585, Villeurbanne, F-69621 France
² INSA-Lyon, Laboratoire de Physiopathologie des Lipides et Membranes, Villeurbanne, F-69621 France
³ IMBL, Villeurbanne, F-69621 France
⁴ Università di Roma-La Sapienza, Dipartimento di Istologia ed Embriologia Medica, Roma, Italy

^* Author for correspondence (e-mail: georges.nemoz{at}insa-lyon.fr)

Accepted 8 November 2006

In L6 skeletal myoblasts induced to differentiate by Arg8-vasopressin treatment, a short-lived lowering of ceramide levels was observed, followed by a long-lasting elevation that was prevented by inhibitors of the de novo synthesis pathway, fumonisin B1 and myriocin. Both inhibitors increased the expression of myogenic differentiation markers and cell fusion rate, whereas short-chain ceramides inhibited these responses. Similar drug effects were observed on primary mouse satellite cell differentiation. Furthermore, bacterial sphingomyelinase overexpression suppressed myogenin nuclear accumulation in L6 cells. These data suggested that endogenous ceramide mediates a negative feedback mechanism limiting myogenic differentiation, and that inhibitors of ceramide synthesis promoted myogenesis by removing this control. Phospholipase D (PLD), a recognized target of ceramide, is required for myogenesis, as shown by the negative effects of PLD1 isoform depletion obtained by siRNA treatment. Fumonisin induced an increase in PLD activity of L6 cells, whereas C6-ceramide decreased it. The expression of PLD1 mRNA transcripts was selectively decreased by C6-ceramide, and increased by ceramide synthesis inhibitors. An early step of myogenic response is the PLD1-dependent formation of actin stress fiber-like structures. C6-ceramide addition or overexpression of sphingomyelinase impaired actin fiber formation. Ceramide might thus regulate myogenesis through downregulation of PLD1 expression and activity.

Key words: Myogenic differentiation, Satellite cells, Ceramide, Phospholipase D, Fumonisin, Cytoskeleton

This article has been cited by other articles:

				F. Sbrana, C. Sassoli, E. Meacci, D. Nosi, R. Squecco, F. Paternostro, B. Tiribilli, S. Zecchi-Orlandini, F. Francini, and L. Formigli Role for stress fiber contraction in surface tension development and stretch-activated channel regulation in C2C12 myoblasts Am J Physiol Cell Physiol, July 1, 2008; 295(1): C160 - C172. [Abstract] [Full Text] [PDF]

				M.-S. Yoon and J. Chen PLD regulates myoblast differentiation through the mTOR-IGF2 pathway J. Cell Sci., February 1, 2008; 121(3): 282 - 289. [Abstract] [Full Text] [PDF]